Clinical trials in Cutaneous lymphoma

The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for cutaneous lymphoma patients.

To find out how you can access one of these clinical trials or to contact us with a question, see our page 'How to be referred'.

For an explanation on the different phases of trials click here.

 

 

Trial Name

 

Description

 

Click for more information (external page)

 

RESMAIN

 

Phase 2 study testing resminostat as treatment for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma.

Suitable for patients who have received treatment and their lymphoma is stable or in remission

 

 

 

Please note, we update these pages fortnightly.

With special thanks to the following:

;